Pyrrolidine

Pyrrolidine

SCHEMBL6582654

C1CCNC1.COc1ccc(-c2nc(-c3cccc(C=O)c3)n(C)n2)cc1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 2/20 0.43
NR1H2 P55055 3/20 0.40
NR1H3 Q13133 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
HSD17B2 P37059 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
ADORA1 P30542 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
AVPR1B P47901 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580839 0.92 KDM4C (0.49) KDM4CNR1H2NR1H3NPC1RAB9A
SCHEMBL6578166 0.87 HSD17B2 (0.51) KDM4CNR1H2NR1H3NPC1RAB9A
SCHEMBL6581144 0.80 NR1H2 (0.53) KDM4CNR1H2NR1H3NPC1RAB9A
SCHEMBL6581289 0.79 DRD1 (0.46) KDM4CNR1H2NR1H3NPC1RAB9A
SCHEMBL6578559 0.78 KCNJ6 (0.41) NPC1RAB9AHDAC1HDAC8HDAC6
SCHEMBL6582814 0.78 NPC1 (0.40) KDM4CNR1H2NR1H3NPC1RAB9A
SCHEMBL6580805 0.78 TGM2 (0.51) NR1H2NR1H3NPC1RAB9AAVPR1B
SCHEMBL6581334 0.78 NPC1 (0.40) KDM4CNR1H2NR1H3NPC1RAB9A
SCHEMBL6581365 0.77 NR1H3 (0.43) NR1H2NR1H3NPC1RAB9AAVPR1B
SCHEMBL6582921 0.77 NR1H3 (0.43) NR1H2NR1H3NPC1RAB9AAVPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070708-B1 Triazole derivatives HOFFMANN LA ROCHE (CH) 2004-01-14 EP disclosed
US-6265426-B1 CENTRAL NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. 2001-07-24 US disclosed
EP-1070708-A1 Triazole and imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2001-01-24 EP disclosed